3 ms·
Seems like there's a lot of opportunity with those unused treatments, if you can get the right arrangement of capital. If the company gives up on pursuit, perha
by boppo1 3y ago
Seems like there's a lot of opportunity with those unused treatments, if you can get the right arrangement of capital. If the company gives up on pursuit, perhaps the'd sell it for less than the R&D cost. Someone could go scoop up 'losers' and find a better way to match them to ailments.
- s1artibartfast 3y agoThis happens. Drug companies sell off IP and technology quite often. The bottle neck is you need someone with a better use hypothesis, and a billion dollars to test that. Drug Trials and development are obscenely expensive.